Finance

Lists
4549:TYO
Eiken Chemical Co Ltd
Â¥2,213.00
-1.07%
(-24.00) 1D
Sep 11, 2:38:09 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
Â¥2,205
High
Â¥2,228
Low
Â¥2,196
Mkt. cap
76.44B
Avg. vol.
251.01K
Volume
85.90K
Dividend
2.62%
Quarterly dividend
Â¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
20.53
52-wk high
Â¥3,500
52-wk low
Â¥2,021
EPS
Â¥108
Shares outstanding
36.88M
No. of employees
696
Open
Â¥2,205
High
Â¥2,228
Low
Â¥2,196
Mkt. cap
76.44B
Avg. vol.
251.01K
Volume
85.90K
Dividend
2.62%
Quarterly dividend
Â¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
20.53
52-wk high
Â¥3,500
52-wk low
Â¥2,021
EPS
Â¥108
Shares outstanding
36.88M
No. of employees
696
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees696
FoundedFeb 20, 1939
Headquarters-
SectorMedical device
Websiteeiken.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
10.23B
10.95B
10.52B
10.73B
Cost of goods sold
5.96B
6.70B
6.97B
6.65B
Cost of revenue
5.96B
6.70B
6.97B
6.65B
Research and development expenses
-
-
3.68B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.34B
3.20B
-262.00M
3.41B
Operating expense
3.34B
3.20B
3.41B
3.41B
Total operating expenses
9.30B
9.90B
10.38B
10.06B
Operating income
928.00M
1.05B
141.00M
668.00M
Other non operating income
6.00M
-54.00M
19.00M
-4.00M
EBT including unusual items
2.91B
1.00B
102.00M
640.00M
EBT excluding unusual items
915.00M
995.00M
-1.89B
640.00M
Income tax expense
535.00M
260.00M
116.00M
195.00M
Effective tax rate
18.36%
25.92%
113.73%
30.47%
Other operating expenses
-
-
-
-
Net income
2.38B
743.00M
-14.00M
445.00M
Net profit margin
23.25%
6.79%
-0.13%
4.15%
Earnings per share
-
-
-
-
Interest and investment income
8.00M
4.00M
5.00M
7.00M
Interest expense
-5.00M
-5.00M
-15.00M
-19.00M
Net interest expenses
3.00M
-1.00M
-10.00M
-12.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.50B
1.62B
775.00M
1.30B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps